Remove Defibrillator Remove Sudden Cardiac Death Remove Tachycardia
article thumbnail

ECG Blog #436 — Bigeminy or Alternans?

Ken Grauer, MD

IMPRESSION: Given the presence of a wide tachycardia — with 2 distinct QRS morphologies, and no sign of P waves — a presumed diagnosis of B i D irectional Ventricular Tachycardia has to be made. Despite prolonged resuscitation with multiple defibrillation attempts — the patient could not be saved. =

Blog 160
article thumbnail

What kind of AV block is this? And why does she develop Ventricular Tachycardia?

Dr. Smith's ECG Blog

Shortly after isoprenalin infusion was initiated, there were short runs of ventricular tachycardia. The biopsy was consistent with cardiac sarcoidosis. She was given CRT-D (Cardiac Resynchronization Therapy-Defibrillator). She was started on isoprenalin (isoproterenol). The above ECG initially shows AV block.

article thumbnail

EV ICD Global Pivotal Trial Results Demonstrate High ATP Success, Effective Defibrillation

DAIC

2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Trial, reinforcing the performance and safety of the EV-ICD system. It works by briefly delivering pacing pulses to the heart at a rate faster than the tachycardia.

article thumbnail

PO-04-179 CATHETER ABLATION VERSUS STANDARD MEDICAL THERAPY AND/OR IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) AS FIRST-LINE THERAPY FOR VENTRICULAR TACHYCARDIA DUE TO STRUCTURAL HEART DISEASE; A SYSTEMATIC REVIEW AND META-ANALYSIS

HeartRhythm

Ventricular tachycardia (VT) poses a significant risk in patients with both ischemic and non-ischemic cardiomyopathy. Implantable cardioverter-defibrillators (ICDs) are placed to prevent sudden cardiac death, but ICD shocks are known to have a negative effect on quality of life and survival.

article thumbnail

MP-470545-005 PREDICTORS OF MONOMORPHIC VENTRICULAR TACHYCARDIA IN PATIENTS WITH SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

HeartRhythm

Subcutaneous implantable cardioverter-defibrillators (S-ICDs) alleviate many issues associated with a transvenous system, while having similar efficacy to transvenous ICDs at preventing sudden cardiac death. However, S-ICDs have higher rates of shocks due to a lack of anti-tachycardia pacing (ATP).

article thumbnail

Efficacy of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy Patients without an ICD Implantation

HeartRhythm

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

article thumbnail

PO-06-198 RISK FACTORS AND OUTCOMES ASSOCIATED WITH FAILED IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS

HeartRhythm

Implantable cardioverter-defibrillators (ICDs) deliver shocks to terminate ventricular tachycardia/ventricular fibrillation (VT/VF) to reduce the risk of sudden cardiac death.